Efficacy and Safety Not Yet Recruiting Phase 2 Trials for Irinotecan (DB00762)

IndicationStatusPhase
DBCOND0085675 (Efficacy and Safety)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03116152Evaluate Efficacy and Safety of IBI308 and Paclitaxel/Irinotecan in Patients With Advanced/Metastatic Esophageal Squamous Cell CarcinomaTreatment